Valbiotis announces its latest capital and voting rights indicators

Valbiotis, a company listed on Euronext Growth Paris, recently published information on its capital composition for the period ending April 30, 2024. The company declared a total of 15,794,596 shares making up the share capital. Furthermore, the theoretical number of voting rights amounts to 16,523,444, while the exercisable voting rights number 16,508,023 after adjustment for treasury shares.

This press release also highlights the importance of respecting the reporting thresholds provided for by the company's statutes and current legislation. Any shareholder crossing a threshold of 5%, 10%, 15%, 20%, 30% of the capital must inform the company by registered letter within four working days.